Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PARL | Q9H300 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12501215 | 0.86 | ALOX12 (0.53) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL16290005 | 0.85 | ALOX12 (0.53) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL9506369 | 0.85 | ALOX12 (0.56) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL16328702 | 0.83 | ALOX12 (0.54) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL6860661 | 0.83 | ALOX12 (0.54) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL19646456 | 0.83 | ALOX12 (0.54) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL1710103 | 0.80 | ALOX12 (0.41) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL13316486 | 0.79 | POLB (0.49) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL6478495 | 0.77 | ALOX12 (0.45) | ALOX12KDM4EPOLBLMNASMN1; SMN2 | |
| SCHEMBL5246024 | 0.76 | ALOX12 (0.47) | ALOX12KDM4EPOLBLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318327-A1 | Kit and Method for Mass Labelling | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2008-12-25 | — | — | US | claimed |
| US-20080293083-A1 | Method and Kit for Peptide Analysis | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2008-11-27 | — | — | US | claimed |
| WO-2007078229-A1 | KIT AND METHOD FOR MASS LABELLING | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2007-07-12 | — | — | WO | claimed |
| WO-2006006924-A1 | METHOD AND KIT FOR PEPTIDE ANALYSIS | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2006-01-19 | — | — | WO | claimed |
| EP-3615586-B1 | BIODEGRADABLE BONE GLUE | EVONIK OPERATIONS GMBH (DE) | 2021-02-17 | — | — | EP | disclosed |
| US-7615646-B2 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | CARNEGIE MELLON UNIVERSITY (US) | 2009-11-10 | — | — | US | disclosed |
| US-20080318327-A1 | Kit and Method for Mass Labelling | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2008-12-25 | — | — | US | disclosed |
| US-20080293083-A1 | Method and Kit for Peptide Analysis | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2008-11-27 | — | — | US | disclosed |
| WO-2007078229-A1 | KIT AND METHOD FOR MASS LABELLING | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2007-07-12 | — | — | WO | disclosed |
| WO-2006006924-A1 | METHOD AND KIT FOR PEPTIDE ANALYSIS | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2006-01-19 | — | — | WO | disclosed |